A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

Clinical trial NCT03398135 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03398135
Sponsor: AbbVie
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)

Start date: 2018-08-28
Primary completion: 2028-09-01
Enrollment: 1242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.